Orntoft TF - Search Results

1

Low ANXA10 expression is associated with disease aggressiveness in bladder cancer.

Munksgaard PP, Mansilla F, Brems Eskildsen AS, Fristrup N, Birkenkamp-Demtröder K, Ulhøi BP, Borre M, Agerbæk M, Hermann GG, Orntoft TF, Dyrskjøt L. Munksgaard PP, et al. Among authors: orntoft tf. Br J Cancer. 2011 Oct 25;105(9):1379-87. doi: 10.1038/bjc.2011.404. Epub 2011 Oct 6. Br J Cancer. 2011. PMID: 21979422 Free PMC article.

2

Expression of TIP60 (tat-interactive protein) and MRE11 (meiotic recombination 11 homolog) predict treatment-specific outcome of localised invasive bladder cancer.

Laurberg JR, Brems-Eskildsen AS, Nordentoft I, Fristrup N, Schepeler T, Ulhøi BP, Agerbaek M, Hartmann A, Bertz S, Wittlinger M, Fietkau R, Rödel C, Borre M, Jensen JB, Orntoft T, Dyrskjøt L. Laurberg JR, et al. BJU Int. 2012 Dec;110(11 Pt C):E1228-36. doi: 10.1111/j.1464-410X.2012.11564.x. Epub 2012 Oct 9. BJU Int. 2012. PMID: 23046361

3

Tumor-promoting macrophages induce the expression of the macrophage-specific receptor CD163 in malignant cells.

Maniecki MB, Etzerodt A, Ulhøi BP, Steiniche T, Borre M, Dyrskjøt L, Orntoft TF, Moestrup SK, Møller HJ. Maniecki MB, et al. Among authors: orntoft tf. Int J Cancer. 2012 Nov 15;131(10):2320-31. doi: 10.1002/ijc.27506. Epub 2012 Mar 28. Int J Cancer. 2012. PMID: 22362417

4

Comprehensive Transcriptional Analysis of Early-Stage Urothelial Carcinoma.

Hedegaard J, Lamy P, Nordentoft I, Algaba F, Høyer S, Ulhøi BP, Vang S, Reinert T, Hermann GG, Mogensen K, Thomsen MBH, Nielsen MM, Marquez M, Segersten U, Aine M, Höglund M, Birkenkamp-Demtröder K, Fristrup N, Borre M, Hartmann A, Stöhr R, Wach S, Keck B, Seitz AK, Nawroth R, Maurer T, Tulic C, Simic T, Junker K, Horstmann M, Harving N, Petersen AC, Calle ML, Steyerberg EW, Beukers W, van Kessel KEM, Jensen JB, Pedersen JS, Malmström PU, Malats N, Real FX, Zwarthoff EC, Ørntoft TF, Dyrskjøt L. Hedegaard J, et al. Among authors: orntoft tf. Cancer Cell. 2016 Jul 11;30(1):27-42. doi: 10.1016/j.ccell.2016.05.004. Epub 2016 Jun 16. Cancer Cell. 2016. PMID: 27321955 Free article.

5

Emmprin and survivin predict response and survival following cisplatin-containing chemotherapy in patients with advanced bladder cancer.

Als AB, Dyrskjøt L, von der Maase H, Koed K, Mansilla F, Toldbod HE, Jensen JL, Ulhøi BP, Sengeløv L, Jensen KM, Orntoft TF. Als AB, et al. Among authors: orntoft tf. Clin Cancer Res. 2007 Aug 1;13(15 Pt 1):4407-14. doi: 10.1158/1078-0432.CCR-07-0109. Clin Cancer Res. 2007. PMID: 17671123

6

Gene signatures for risk-adapted treatment of bladder cancer.

Ørntoft TF, Dyrskjøt L. Ørntoft TF, et al. Scand J Urol Nephrol Suppl. 2008 Sep;(218):166-74. doi: 10.1080/03008880802283730. Scand J Urol Nephrol Suppl. 2008. PMID: 18815931 Review.

7

Genomic profiling of microRNAs in bladder cancer: miR-129 is associated with poor outcome and promotes cell death in vitro.

Dyrskjøt L, Ostenfeld MS, Bramsen JB, Silahtaroglu AN, Lamy P, Ramanathan R, Fristrup N, Jensen JL, Andersen CL, Zieger K, Kauppinen S, Ulhøi BP, Kjems J, Borre M, Orntoft TF. Dyrskjøt L, et al. Among authors: orntoft tf. Cancer Res. 2009 Jun 1;69(11):4851-60. doi: 10.1158/0008-5472.CAN-08-4043. Cancer Res. 2009. PMID: 19487295

8

High frequency of tumor cells with nuclear Egr-1 protein expression in human bladder cancer is associated with disease progression.

Egerod FL, Bartels A, Fristrup N, Borre M, Ørntoft TF, Oleksiewicz MB, Brünner N, Dyrskjøt L. Egerod FL, et al. Among authors: orntoft tf. BMC Cancer. 2009 Oct 30;9:385. doi: 10.1186/1471-2407-9-385. BMC Cancer. 2009. PMID: 19878561 Free PMC article.

9

Coordinated epigenetic repression of the miR-200 family and miR-205 in invasive bladder cancer.

Wiklund ED, Bramsen JB, Hulf T, Dyrskjøt L, Ramanathan R, Hansen TB, Villadsen SB, Gao S, Ostenfeld MS, Borre M, Peter ME, Ørntoft TF, Kjems J, Clark SJ. Wiklund ED, et al. Among authors: orntoft tf. Int J Cancer. 2011 Mar 15;128(6):1327-34. doi: 10.1002/ijc.25461. Int J Cancer. 2011. PMID: 20473948

10

Prediction and diagnosis of bladder cancer recurrence based on urinary content of hTERT, SENP1, PPP1CA, and MCM5 transcripts.

Brems-Eskildsen AS, Zieger K, Toldbod H, Holcomb C, Higuchi R, Mansilla F, Munksgaard PP, Borre M, Ørntoft TF, Dyrskjøt L. Brems-Eskildsen AS, et al. Among authors: orntoft tf. BMC Cancer. 2010 Nov 24;10:646. doi: 10.1186/1471-2407-10-646. BMC Cancer. 2010. PMID: 21106093 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

379 results

Search Page

Filters